Macrotroponin in the COVID-19 Era: An Under-Recognised Cause of Persistent Troponin Elevation.

Kempton, Hannah; Jones, Graham; McCready, Michael; Kovacic, Jason

Kempton, Hannah; Jones, Graham; McCready, Michael; Kovacic, Jason.

Afiliação

Kempton H; Department of Cardiology, St Vincent's Hospital, Sydney, NSW, Australia; The University of New South Wales, Sydney, NSW, Australia. Electronic address: hannah.kempton2@svha.org.au.
Jones G; Department of Pathology, St Vincent's Hospital, Sydney, NSW, Australia.
McCready M; Department of Cardiology, Wagga Wagga Base Hospital, Wagga Wagga, NSW, Australia.
Kovacic J; Department of Cardiology, St Vincent's Hospital, Sydney, NSW, Australia; The University of New South Wales, Sydney, NSW, Australia; The Victor Chang Cardiac Research Institute, Sydney, NSW, Australia.

Heart Lung Circ ; 33(8): 1147-1150, 2024 Aug.

Article em En | MEDLINE | ID: mdl-38705780

ABSTRACT

ABSTRACT

Troponin is an important diagnostic tool, however, as the assay sensitivity and frequency of testing has increased in the COVID-19 era, a new cohort of patients with persistently elevated troponin has emerged. Interfering antibodies should be considered in patients with persistent and stable troponin elevation, where there is no ongoing cause.

Assuntos

COVID-19; SARS-CoV-2; Humanos; COVID-19/sangue; COVID-19/diagnóstico; Masculino; Feminino; Biomarcadores/sangue; Troponina/sangue; Pessoa de Meia-Idade; Idoso

Palavras-chave

Macrotroponin; Myocardial infarction; Troponin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google